Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
9.75
-0.44 (-4.32%)
At close: May 29, 2026, 4:00 PM EDT
9.64
-0.11 (-1.18%)
After-hours: May 29, 2026, 6:25 PM EDT
Nuvectis Pharma Employees
Nuvectis Pharma had 12 employees as of March 31, 2026. The number of employees decreased by 1 or -7.69% compared to the same quarter last year.
Employees
12
Change
-1
Growth
-7.69%
Revenue / Employee
n/a
Profits / Employee
-$2,465,750
Market Cap
258.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 12 | -1 | -7.69% |
| Dec 31, 2025 | 13 | 0 | - |
| Sep 30, 2025 | 13 | 0 | - |
| Jun 30, 2025 | 13 | 0 | - |
| Mar 31, 2025 | 13 | 0 | - |
| Dec 31, 2024 | 13 | 0 | - |
| Sep 30, 2024 | 13 | 0 | - |
| Jun 30, 2024 | 13 | - | - |
| Dec 31, 2023 | 13 | 2 | 18.18% |
| Dec 31, 2022 | 11 | 3 | 37.50% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Cellectis | 229 |
| Entrada Therapeutics | 152 |
| Codexis | 146 |
| Adagene | 128 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| SAB Biotherapeutics | 86 |
NVCT News
- 12 days ago - Nuvectis Pharma Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 17 days ago - Nuvectis Pharma, Inc. To Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - GlobeNewsWire
- 20 days ago - Nuvectis Pharma Slides: Corporate presentation - Filings
- 26 days ago - Nuvectis Pharma, Inc. Reports First Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 26 days ago - Nuvectis Pharma Earnings release: Q1 2026 - Filings
- 26 days ago - Nuvectis Pharma Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Nuvectis Pharma Proxy statement: Proxy filing - Filings
- 4 weeks ago - Nuvectis Pharma Proxy statement: Proxy filing - Filings